Methodist Childrens Hospital

San Antonio, Texas 78229

2 studies enrolling now · 7 studies all time

What they study most

B-Cell Acute Lymphoblastic Leukemia, Birth Asphyxia, Extreme Prematurity, Infant, Extremely Premature, Intensive Care Units, Neonatal, Intensive Care, Neonatal, Neonatal Encephalopathy, Obstetric Labor, Premature, Patent Ductus Arteriosus, Premature Birth, Relapsed or Refractory B Cell Acute Lymphoblastic Leukemia, Relapsed or Refractory B Cell Non-Hodgkin Lymphoma

Studies at this site

• Multisite Inventory of Neonatal-Perinatal Interventions (MINI) Minimum Dataset — Recruiting now
• A Study of CD19 Targeted CAR T Cell Therapy in Pediatric Patients With Relapsed or Refractory B Cell Acute Lymphoblastic Leukemia (B ALL) and Aggressive Mature B-cell Non-Hodgkin Lymphoma (B NHL) — Recruiting now
• Study of Efficacy and Safety of Tisagenlecleucel in HR B-ALL EOC MRD Positive Patients — Running, not enrolling
• Preterm Erythropoietin Neuroprotection Trial (PENUT Trial) — Completed
• A Dose-Ranging Study to Determine the Efficacy, Safety and Tolerability of AeroFact — Completed
• High-dose Erythropoietin for Asphyxia and Encephalopathy — Completed
• PDA Post NICU Discharge — Completed